Improvement in in vitro fertilization outcome following in vivo synchronization of oocyte maturation in mice

Cilostazol administered to female mice induces ovulation of immature oocytes: A contraceptive animal model

(2014) Ahmed M. Taiyeb et al.   LIFE SCIENCES

In vitroeffects of cilostazol, a phosphodiesterase 3A inhibitor, on mouse oocyte maturation and morphology

(2013) Ahmed M Taiyeb et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Cilostazol blocks pregnancy in naturally cycling mice

(2012) Ahmed M. Taiyeb Albarzanchi et al.   CONTRACEPTION

The competence of germinal vesicle oocytes is unrelated to nuclear chromatin configuration and strictly depends on cytoplasmic quantity and quality in the cat model

(2011) P. Comizzoli et al.   HUMAN REPRODUCTION

253 OOCYTE PREMATURATION IN THE PRESENCE OF MILRINONE IMPROVES NUCLEAR BUT NOT CYTOPLASMIC MATURATION OF MACAQUE OOCYTES

(2011) E. C. Curnow et al.   REPRODUCTION FERTILITY AND DEVELOPMENT

Simulated physiological oocyte maturation (SPOM): a novel in vitro maturation system that substantially improves embryo yield and pregnancy outcomes

(2010) F. K. Albuz et al.   HUMAN REPRODUCTION

Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 andABCB1

(2009) Hee-Doo Yoo et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Effect of a phosphodiesterase type 3 inhibitor in oocyte maturation medium on subsequent mouse embryo development

(2008) Byung Chul Jee et al.   FERTILITY AND STERILITY

A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles

(2008) W.-Y. Son et al.   HUMAN REPRODUCTION

Effect of temporary nuclear arrest by Phosphodiesterase 3-Inhibitor on morphological and functional aspects of in vitro matured mouse oocytes

(2007) Leen Vanhoutte et al.   MOLECULAR REPRODUCTION AND DEVELOPMENT